Mandate

VINGE ADVISES INDUSTRIFONDEN IN CONNECTION WITH INVESTMENT IN INRIVER

August 14, 2013

Vinge has advised Industrifonden which, together with Zobito, has invested a total of SEK 20 million in the Malmö-based software company, inRiver. inRiver’s software helps companies to manage product information in a simpler and more expeditious manner. The funds will be used to finance inRiver’s future international expansion in the US and other countries.

inRiver’s software allows customers to quickly and efficiently collect all product information by uploading texts in different languages, pictures of products and films in inRiver’s software – a process which is called Product Information Management (PIM). Products are placed on the market more quickly with PIM and the information can thereafter be quickly distributed and easily adapted for marketing and sales materials via various sales channels.

The company has expanded significantly in the last few years and has managed to achieve a leading position in the Nordic region in its field with customers such as Stadium, Lindex, Fazer, Gant, Haléns and Byggmax. iRiver has now commenced its international expansion by, among other things, establishing subsidiaries in the US and the Netherlands.

Vinge’s team consisted primarily of partner Johan Larsson and associates Karl Hahtovirta and Philip Watson.   

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026